These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 526675)

  • 21. [An update on cardiovascular diseases in the elderly--the prophylactic, diagnostic and treatment aspects].
    Popescu P; Ilieşiu A
    Med Interna; 1991; 43(1-2):7-19. PubMed ID: 1670127
    [No Abstract]   [Full Text] [Related]  

  • 22. Antalya statement of the International Society of Hypertension on the prevention of blood pressure-related diseases.
    Chockalingam A; Chalmers J; Whitworth J; Erdine S; Mancia G; Mendis S; Heagerty A
    J Hypertens; 2008 Dec; 26(12):2255-8. PubMed ID: 19008700
    [No Abstract]   [Full Text] [Related]  

  • 23. American College of Sports Medicine. Position Stand. Physical activity, physical fitness, and hypertension.
    Med Sci Sports Exerc; 1993 Oct; 25(10):i-x. PubMed ID: 8231750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and control of high blood pressure: challenges and opportunities.
    Campbell NR; Chockalingam A
    CMAJ; 1995 Jun; 152(12):1969-70. PubMed ID: 7780906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Factors affecting the control of blood pressure and lipid levels in patients with cardiovascular disease: the PREseAP Study].
    Orozco-Beltrán D; Brotons C; Moral I; Soriano N; Del Valle MA; Rodríguez AI; Pepió JM; Pastor A;
    Rev Esp Cardiol; 2008 Mar; 61(3):317-21. PubMed ID: 18361907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A five-year report (1975-1979) of community control of cardiovascular diseases in Shijingshan People's commune of Beijing (author's transl)].
    Yu JS
    Zhonghua Yi Xue Za Zhi; 1981 Jan; 61(1):44-7. PubMed ID: 6805880
    [No Abstract]   [Full Text] [Related]  

  • 28. [Theoretical and practical problems in the control of cardiovascular diseases].
    Anders G; Heine H
    Z Arztl Fortbild (Jena); 1974 Apr; 68(8):376-8. PubMed ID: 4411239
    [No Abstract]   [Full Text] [Related]  

  • 29. 1999 World Health Organization--International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-Committee.
    Blood Press Suppl; 1999; 1():9-43. PubMed ID: 10401540
    [No Abstract]   [Full Text] [Related]  

  • 30. 1991 guidelines for the prevention of hypertension and associated cardiovascular disease. Joint World Health Organization/International Society of Hypertension Meeting.
    J Hypertens; 1992 Jan; 10(1):97-9. PubMed ID: 1312559
    [No Abstract]   [Full Text] [Related]  

  • 31. IX-1993 guidelines for management of mild hypertension. WHO/ISH Mild Hypertension Liaison Committee.
    Clin Exp Hypertens; 1993 Nov; 15(6):1363-95. PubMed ID: 8268896
    [No Abstract]   [Full Text] [Related]  

  • 32. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum.
    Smith SC; Jackson R; Pearson TA; Fuster V; Yusuf S; Faergeman O; Wood DA; Alderman M; Horgan J; Home P; Hunn M; Grundy SM
    Circulation; 2004 Jun; 109(25):3112-21. PubMed ID: 15226228
    [No Abstract]   [Full Text] [Related]  

  • 33. The several faces of clinical trials: from new therapies to failed preventive strategies.
    Fuster V
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):173. PubMed ID: 16568110
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular and hypertension targets in the health plan for Catalonia (Spain).
    Pardell H; Tresserras R; Taberner JL; Via JM; Salleras L
    J Hum Hypertens; 1993 Dec; 7(6):543-5. PubMed ID: 8114043
    [No Abstract]   [Full Text] [Related]  

  • 35. Physician practice for cardiovascular disease risk-factor reduction in six upper Midwestern communities.
    Kofron PM; Råstam L; Pirie PL; Holder W; Leupker RV
    J Fam Pract; 1991 Jan; 32(1):49-55. PubMed ID: 1985135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arterial hypertension, non-drug treatment and cardiovascular risk].
    Blacher J; Tartiere JM; Amah G; Campa P; Raison J; Safar M
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):81-5. PubMed ID: 9772933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to volume control, cardiac preservation, and blood pressure control in the pre-end-stage renal disease patient.
    Henrich WL
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S63-5. PubMed ID: 11443770
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular perspectives of reducing high blood pressure.
    Birkenhäger WH; de Leeuw PW
    Neth J Med; 1989 Jun; 34(5-6):229-32. PubMed ID: 2770936
    [No Abstract]   [Full Text] [Related]  

  • 39. Community-based approach to control mild hypertension.
    Puska P; Pietinen P; Nissinen A; Tuomilehto J; Piha T
    J Clin Hypertens; 1986 Jun; 2(2):203-9. PubMed ID: 3760915
    [No Abstract]   [Full Text] [Related]  

  • 40. [The basic treatment of arterial hypertension (I). Changes in life style and the control of risk factors].
    Pascual J; Quereda C; Ortuño J
    Med Clin (Barc); 1994 Oct; 103(14):547-52. PubMed ID: 7799669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.